Cargando…
Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study
CONTEXT: Diabetes mellitus (DM) is associated with the development of pancreatic cancer (PaC), but few large-scale studies have examined its predictive risk factors. OBJECTIVE: The present study aims to examine the predictors for PaC in patients with type 2 diabetes mellitus (T2DM) in a territory-wi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562787/ https://www.ncbi.nlm.nih.gov/pubmed/36267596 http://dx.doi.org/10.1210/jendso/bvac138 |
_version_ | 1784808253637525504 |
---|---|
author | Chan, Raymond Ngai Chiu Lee, Teddy Tai Loy Chou, Oscar Hou In So, Jenny Chung, Cheuk To Dee, Edward Christopher Ng, Kenrick Tang, Pias Roever, Leonardo Liu, Tong Wong, Wing Tak Tse, Gary Lee, Sharen |
author_facet | Chan, Raymond Ngai Chiu Lee, Teddy Tai Loy Chou, Oscar Hou In So, Jenny Chung, Cheuk To Dee, Edward Christopher Ng, Kenrick Tang, Pias Roever, Leonardo Liu, Tong Wong, Wing Tak Tse, Gary Lee, Sharen |
author_sort | Chan, Raymond Ngai Chiu |
collection | PubMed |
description | CONTEXT: Diabetes mellitus (DM) is associated with the development of pancreatic cancer (PaC), but few large-scale studies have examined its predictive risk factors. OBJECTIVE: The present study aims to examine the predictors for PaC in patients with type 2 diabetes mellitus (T2DM) in a territory-wide, retrospective cohort study. METHODS: This was a territory-wide, retrospective cohort study of patients with T2DM mellitus older than 40 years with no prior history of PaC. Baseline demographics, use of antidiabetic medications, comorbidities, and biochemical parameters were extracted. Cox regression was used to calculate hazard ratios (HR) with 95% CI. Subgroup analyses based on chronic kidney disease (CKD) stages were performed. RESULTS: This study consisted of 273 738 patients (age = 65.4 ± 12.7 years, male = 48.2%, follow-up duration = 3547 ± 1207 days, disease duration = 4.8 ± 2.3 years), of whom 1148 developed PaC. The number of antidiabetic medications prescribed (HR: 1.20; 95% CI, 1.01-1.42; P = .040), diabetic microvascular complications (HR: 1.91; 95% CI, 1.30-2.81; P < .001), chronic kidney disease (HR: 1.81; 95% CI, 1.25-2.64; P = .002), use of acarbose (HR: 2.24; 95% CI, 1.35-3.74; P = .002), and use of glucagon-like peptide-1 receptor agonist (HR: 4.00; 95% CI: 1.28-12.53, P = .017) were associated with PaC development on multivariable Cox regression adjusting for the duration of DM, mean glycated hemoglobin A(1c), and history of pancreatic diseases. Stage 3A CKD or below was associated with PaC but not stage 3B or beyond. CONCLUSION: Diabetic microvascular complications, especially stage 1, 2, and 3A CKD, were associated with PaCs. |
format | Online Article Text |
id | pubmed-9562787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95627872022-10-19 Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study Chan, Raymond Ngai Chiu Lee, Teddy Tai Loy Chou, Oscar Hou In So, Jenny Chung, Cheuk To Dee, Edward Christopher Ng, Kenrick Tang, Pias Roever, Leonardo Liu, Tong Wong, Wing Tak Tse, Gary Lee, Sharen J Endocr Soc Clinical Research Article CONTEXT: Diabetes mellitus (DM) is associated with the development of pancreatic cancer (PaC), but few large-scale studies have examined its predictive risk factors. OBJECTIVE: The present study aims to examine the predictors for PaC in patients with type 2 diabetes mellitus (T2DM) in a territory-wide, retrospective cohort study. METHODS: This was a territory-wide, retrospective cohort study of patients with T2DM mellitus older than 40 years with no prior history of PaC. Baseline demographics, use of antidiabetic medications, comorbidities, and biochemical parameters were extracted. Cox regression was used to calculate hazard ratios (HR) with 95% CI. Subgroup analyses based on chronic kidney disease (CKD) stages were performed. RESULTS: This study consisted of 273 738 patients (age = 65.4 ± 12.7 years, male = 48.2%, follow-up duration = 3547 ± 1207 days, disease duration = 4.8 ± 2.3 years), of whom 1148 developed PaC. The number of antidiabetic medications prescribed (HR: 1.20; 95% CI, 1.01-1.42; P = .040), diabetic microvascular complications (HR: 1.91; 95% CI, 1.30-2.81; P < .001), chronic kidney disease (HR: 1.81; 95% CI, 1.25-2.64; P = .002), use of acarbose (HR: 2.24; 95% CI, 1.35-3.74; P = .002), and use of glucagon-like peptide-1 receptor agonist (HR: 4.00; 95% CI: 1.28-12.53, P = .017) were associated with PaC development on multivariable Cox regression adjusting for the duration of DM, mean glycated hemoglobin A(1c), and history of pancreatic diseases. Stage 3A CKD or below was associated with PaC but not stage 3B or beyond. CONCLUSION: Diabetic microvascular complications, especially stage 1, 2, and 3A CKD, were associated with PaCs. Oxford University Press 2022-09-05 /pmc/articles/PMC9562787/ /pubmed/36267596 http://dx.doi.org/10.1210/jendso/bvac138 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Article Chan, Raymond Ngai Chiu Lee, Teddy Tai Loy Chou, Oscar Hou In So, Jenny Chung, Cheuk To Dee, Edward Christopher Ng, Kenrick Tang, Pias Roever, Leonardo Liu, Tong Wong, Wing Tak Tse, Gary Lee, Sharen Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study |
title | Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study |
title_full | Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study |
title_fullStr | Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study |
title_full_unstemmed | Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study |
title_short | Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study |
title_sort | risk factors of pancreatic cancer in patients with type 2 diabetes mellitus: the hong kong diabetes study |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562787/ https://www.ncbi.nlm.nih.gov/pubmed/36267596 http://dx.doi.org/10.1210/jendso/bvac138 |
work_keys_str_mv | AT chanraymondngaichiu riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT leeteddytailoy riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT chouoscarhouin riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT sojenny riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT chungcheukto riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT deeedwardchristopher riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT ngkenrick riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT tangpias riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT roeverleonardo riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT liutong riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT wongwingtak riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT tsegary riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy AT leesharen riskfactorsofpancreaticcancerinpatientswithtype2diabetesmellitusthehongkongdiabetesstudy |